Bonnefoy J Y, Pochon S, Aubry J P, Graber P, Gauchat J F, Jansen K, Flores-Romo L
Glaxo Institute for Molecular Biology, Ouates/Geneva, Switzerland.
Immunol Today. 1993 Jan;14(1):1-2. doi: 10.1016/0167-5699(93)90313-A.
The molecules controlling IgE production are the subject of intense study in the effort to find new ways to treat allergic diseases. One candidate, the CD23 molecule, a low affinity receptor for IgE, was recently identified to interact with another molecule, named CD21, in the regulation of IgE production.
为寻找治疗过敏性疾病的新方法，控制IgE产生的分子成为了深入研究的对象。一种名为CD23分子的候选分子，它是IgE的低亲和力受体，最近被确定在IgE产生的调节过程中与另一种名为CD21的分子相互作用。
